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Plastic stents used for the treatment of biliary obstruction will become occluded over time
due to microbial colonization and formation of biofilms. Treatment of stent-associated cho-
langitis is often not effective because of inappropriate use of antimicrobial agents or antimi-
crobial resistance. We aimed to assess the current bacterial and fungal etiology of stent-
associated biofilms, with particular emphasis on antimicrobial resistance.
Methods
Patients with biliary strictures requiring endoscopic stent placement were prospectively
enrolled. After the retrieval of stents, biofilms were disrupted by sonication, microorganisms
were cultured, and isolates were identified by matrix-associated laser desorption/ionization
time-of-flight (MALDI-TOF) mass spectrometry and/or biochemical typing. Finally, minimum
inhibitory concentrations (MICs) were determined for various antimicrobial agents. Selected
stents were further analyzed by fluorescence in situ hybridization (FISH).
Results
Among 120 patients (62.5% males, median age 64 years) with biliary strictures (35%malig-
nant, 65% benign), 113 double pigtail polyurethane and 100 straight polyethylene stents
were analyzed after a median indwelling time of 63 days (range, 1–1274 days). The stent
occlusion rate was 11.5% and 13%, respectively, being associated with a significantly
increased risk of cholangitis (38.5% vs. 9.1%, P<0.001). Ninety-five different bacterial and
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13 fungal species were detected; polymicrobial colonization predominated (95.8% vs.
4.2%, P<0.001). Enterococci (79.3%), Enterobacteriaceae (73.7%), and Candida spp.
(55.9%) were the leading pathogens. Candida species were more frequent in patients previ-
ously receiving prolonged antibiotic therapy (63% vs. 46.7%, P = 0.023). Vancomycin-
resistant enterococci accounted for 13.7%, extended-spectrum beta-lactamase (ESBL)-
producing Enterobacteriaceae with co-resistance to ciprofloxacin accounted for 13.9%, and
azole-resistant Candida spp. accounted for 32.9% of the respective isolates.
Conclusions
Enterococci and Candida species play an important role in the microbial colonization of bili-
ary stents. Therefore, empirical antimicrobial treatment of stent-associated cholangitis
should be guided toward enterococci, Enterobacteriaceae, streptococci, anaerobes, and
Candida. To determine causative pathogens, an accurate microbiological analysis of the
extracted stent(s) may be helpful.
Introduction
Obstruction of the biliary system by malignancies, anastomotic stenosis after liver transplanta-
tion, chronic pancreatitis, or gallstones that are not immediately extractable endoscopically
prevents the drainage of bile fluids from the liver and gall bladder to the small intestine and
results in obstructive jaundice [1–3]. Gold standard for palliative treatment of an obstructed
bile duct is the insertion of a stent by endoscopic retrograde cholangiopancreatography
(ERCP) to restore bile fluid drainage [2,3]. However, sooner or later, biliary stents become col-
onized by microorganisms and ultimately occluded by a sludge (Fig 1) composed of bacteria,
fungi, proteins, calcium bilirubinate, calcium palmitate, cholesterol, and plant fibers, leading
to recurrent cholestasis or cholangitis [1,4–9]. The risk for stent occlusion depends on the
indwelling time of the stent [1–3,8,10]. According to available studies, median patency of plas-
tic stents ranges between 70 and 126 days [2,3,8,10]. Therefore, most endoscopy units perform
stent exchanges at a programmed interval of three months to avoid stent occlusion [2,10,11].
Self-expanding metal stents may double the patency time as compared to straight polyethylene
stents [12]. The application of antibiotics, such as ofloxacin, alone or in combination with urso-
deoxycholic acid, has failed in preventing stent occlusion [13].
A broad range of studies suggest that bacterial adhesion to artificial surfaces, resulting in the
formation of biofilms, drives sludge development ahead [10,14–22]. A biofilm is a structured
consortium of microorganisms embedded in a self-produced polymer matrix consisting of
polysaccharides, proteins, and deoxyribonucleic acid (DNA). This consortium can consist of
one or more species living in a sociomicrobiological way [21]. Bacterial biofilms predispose for
chronic infections because indwelling microorganisms show increased tolerance to antibiotics
and disinfectant chemicals as well as resist phagocytosis and other components of the body’s
defense system [21]. In a pioneering study published in 1988, Leung et al. perfused biliary
stents with either bacterially contaminated or sterile bile fluid [14]. Scanning electron micros-
copy revealed a dense layer of bacteria and amorphous material on the surface of the stents
which were perfused with bacterially contaminated bile. In contrast, this phenomenon was not
observed in experiments using sterile bile only [14].
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The clinical management of biofilm-associated infections is challenging because the
microbes in the stent are not generally amenable to eradication employing antimicrobial che-
motherapy [1]. Thus, the occluded device must be replaced endoscopically, which requires an
elaborate and, from the perspective of the patient, stressful procedure. Although stent replace-
ment may be repeated several times, stent lifetime tends to decrease progressively, presumably
because relevant microbes that have adapted to the stent niche accumulate within the bile duct
[1]. Biofilms developing on biliary stents usually consist of a broad and diverse spectrum of
mixed microbial communities [1,17,19]. However, many bacteria of the gut microbiota may
not presently be cultivated by standard laboratory procedures. Thus, existing data on biliary
stent microbial communities may be biased and incomplete [1]. Notably, even available infor-
mation on culturable bacteria is not static and shows a recent trend toward pathogens such as
extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae, enterococci, and
Candida species [10,23–28]. Thus, standard antimicrobial therapy concepts for patients with
cholangitis, which mainly target sensitive Enterobacteriaceae and anaerobes, need to be reeval-
uated [25–28].
We performed this prospective cohort study to determine the current bacterial and fungal
etiology of biofilm formation in biliary stents, with particular emphasis on antibiotic therapy
and thereby exerted selective pressure. A further objective was to assess the dynamics of patho-
gens and the epidemiology of antimicrobial resistance compared to what was found in previous
studies [10,14,17,19,20,23,24].
Patients and Methods
Study population and study design
From June 2013 to March 2015, 120 patients with biliary strictures and elective or emergency
stent exchanges were consecutively enrolled. Stent exchanges were performed at the interdisci-
plinary endoscopy unit of the Leipzig University Hospital (Leipzig, Germany) by experienced
endoscopic examiners (personal record of>250 ERCPs).
Fig 1. Endoscopic extraction of occluded biliary polyethylene stents (double stenting in a 52 year-old
patient with biliary stenosis due to chronic pancreatitis).
doi:10.1371/journal.pone.0155479.g001
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Ethics approval
The study was performed in accordance with the ethical guidelines of the 1964 Declaration of
Helsinki and was approved by the local ethics committee (University of Leipzig, register no.
059-13-11032013). As the study did not modify patient management, and as the data were pro-
cessed anonymously, the need for informed consent was waived according to the ethics com-
mittee approval.
Interventional endoscopic procedure
ERC was performed using standard videoduodenoscopes of the Fujinon ED-530 series (Fuji-
non, Japan). First, the position of the indwelling biliary stent(s) was documented by direct
endoscopic visualization and x-ray. Afterwards, (a) stent(s) was (were) grasped by a snare or
forceps and then extracted by complete retraction of the endoscope through the stomach, the
esophagus, the pharynx, and the oral cavity. Subsequently, a 5F catheter was inserted into the
biliary tract, and contrast fluid was injected. Depending on the results of previous and current
cholangiograms, either (a) new stent(s) was (were) inserted, or the stent therapy was ended.
The caliber of subsequent stent placements varied between 8F and 11.5F, as in the previous
intervention.
Stent characteristics and stent preparation
All extracted stents were made of either polyethylene (straight stents from Cook Medical, Ire-
land, or from Boston Scientific, USA) or polyurethane (double pigtail stents from Optimed,
Germany). To minimize the risk of contamination, and to provide the best possible pre-ana-
lytic conditions, 3–4 centimeters of the distal end of the extracted stent(s), previously located
in the intestinal lumen, were removed using sterile scissors, and immediately thereafter, stents
were immersed in a sterile nutrient solution (Brain Heart Infusion Broth; Merck, Germany).
Transport to the microbiology laboratory was performed on the same day, where the stent(s)
was (were) worked up according to a standardized protocol. In patients with multi-stenting,
only one stent was submitted for microbiological analysis.
Definition of stent occlusion
Before starting the sonication process, an assessment of the drainage function of the stent was
carried out in the microbiology laboratory. Hereby, encrusted sludge completely narrowing the
stent lumen was defined as inner stent occlusion, as described previously [10].
Sonication process
In the microbiology laboratory, the prepared stent was put into a sterile container (Bandelin,
Germany) and completely covered with 50 ml of sterile Ringer’s solution. To disrupt the bio-
film on the inner surface of the stent, the specimen was vortexed for 30 seconds and subse-
quently exposed to low-frequency (40 kHz) ultrasound for 15 minutes, as described previously
[10,29,30]. Sonication was performed in an ultrasound bath specially designed for microbiolog-
ical analysis (BactoSonic1; Bandelin, Germany). Thereafter, the container was vortexed again
for 30 seconds.
Microbiological analysis
Aliquots of the sonication fluid were cultivated on conventional solid media (sheep blood agar,
blood agar, chocolate agar, Esculin agar, Endo agar, Columbia agar with and without gentami-
cin supplementation, CHROMagar™ ESBL, and Sabouraud agar) and incubated in aerobic and
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anaerobic atmospheres at 37°C (Heraeus Incubator Series 6000; Thermo Scientific, Germany),
as described previously [10]. Aerobic cultures were incubated for at least 48 hours, and anaero-
bic cultures for 96 hours. All bacterial isolates were identified using a matrix-associated laser
desorption/ionization time-of-flight mass spectrometer (MALDI-TOF MS; bioMérieux,
France). Fungal isolates were submitted to a commercially available assimilation test (ID 32 C
yeast identification system; bioMérieux, France) for species identification.
Antimicrobial susceptibility testing
Depending on the Gram stain nature of the bacterial isolates, minimum inhibitory concentra-
tions (MICs) were established according to International Organization for Standardization
(ISO) 20776–1 for the following antimicrobial agents: penicillin G, ampicillin, oxacillin, pipera-
cillin, ampicillin/sulbactam, piperacillin/tazobactam, cefuroxime, cefotaxime, ceftazidime, imi-
penem, meropenem, gentamicin, ciprofloxacin, levofloxacin, moxifloxacin, erythromycin,
clindamycin, vancomycin, teicoplanin, rifampicin, linezolid, daptomycin, doxycycline, tri-
methoprim/sulfamethoxazole, fosfomycin, colistin, and metronidazole. Tigecycline was tested
using gradient strips (Etest1; bioMérieux, France). E-tests were also used for fungal isolates
determining MICs for amphotericin B, flucytosine, fluconazole, itraconazole, posaconazole,
voriconazole, and caspofungin. Susceptibilities were assessed using breakpoints established by
the European Committee on Antimicrobial Susceptibility Testing (EUCAST, www.eucast.org,
2015 edition) [31]. Phenotypic ESBL production was confirmed using appropriate E-tests (bio-
Mérieux, France), as described previously [32].
Visualization of biofilm formation
In selected cases, biofilms were visualized by fluorescence in situ hybridization (FISH) (Fig 2)
in the Biofilm Center of the German Heart Institute (Berlin, Germany), as described previously
[33,34].
Blood cultures
Blood cultures were collected only in patients presenting with acute cholangitis or general signs
of infection.
Statistical analysis
Statistical analysis was performed using SPSS for Windows (SPSS 20.0, IBM Corporation,
Armonk, New York, USA). Numerical variables were summarized as medians, and categorical
variables were given as frequencies or proportions. Confidence intervals (CI) for frequencies
were calculated based on binomial distribution. Categorical data were analyzed by the chi-
square test or Fisher’s exact test. For the comparison of two independent groups, the nonpara-
metric Mann-Whitney U test was used. Independent predictors for the occurrence of entero-
cocci or Candida species were identified using multiple logistic regression. For comparing the
time-dependent persistence of pathogens, the log-rank test was applied. P values (two-sided) of
<0.05 were considered statistically significant.
Results
Patients and stent characteristics
One-hundred and twenty patients (62.5% males, 37.5% females, median age 64 years) with bili-
ary strictures (35% with malignant strictures, 20.8% after liver transplantation, 18.3% due to
gallstones, 9.2% due to chronic pancreatitis, 16.7% due to other reasons) requiring endoscopic
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stent placement previously were prospectively enrolled in the study (Table 1). Preventive stent
replacements accounted for 60.6% (129/213) of the procedures. Forty of 120 patients (33.3%)
had repeating stenting procedures.
In these patients, 213 biliary stents (113 double pigtail stents, 100 straight plastic stents)
were microbiologically analyzed after endoscopic retrieval (Fig 3). The median time of biliary
stent placement was 63 days (range, 1–1274 days). The stent occlusion rate was 11.5% (13/113;
95% CI: 6.3% to 18.9%) in double pigtail stents, and it was 13% (13/100; 95% CI: 7.1% to
21.2%) in straight polyethylene stents. The analysis of the laboratory markers at baseline
revealed a statistically significant difference only for alkaline phosphatase (AP) values
(P = 0.007), presumably due to a slightly better drainage function of straight stents compared
to double pigtail stents.
The clinical cholangitis rate (defined by the occurrence of fever, abdominal pain, jaundice,
pus coming out of the papilla) was 20% (24/120; 95% CI: 13.3% to 28.3%). Three patients had
multiple cholangitis episodes due to repeating stenting procedures. The risk of cholangitis
was significantly higher in patients with stent occlusion (38.5% vs. 9.1%, P<0.001). Eighty-six
of the 120 patients (71.7%) received antibiotic treatments during stent insertion, mainly
Fig 2. Presence of biofilm formation on a biliary polyethylene stent in a 62-year-old liver transplant
recipient with anastomotic bile duct stenosis, visualized by fluorescence in situ hybridization (FISH).
Using cultures, Enteroccus faecalis and Escherichia coli were detected.
doi:10.1371/journal.pone.0155479.g002
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Table 1. Baseline characteristics of the patients and stents.
Number of patients 120
Median age in years (range) 64 (7–91)
Male sex (%) 75 (62.5%)
Reason for stent therapy
Malignant disease (%) 42 (35%)
Cholangiocarcinoma (%) 26 (21.7%)
Pancreatic cancer (%) 6 (5%)
Other malignancy (%) 10 (8.3%)
Benign disease (%) 78 (65%)
Anastomotic stenosis after liver transplantation (LTx) (%) 25 (20.8%)
Choledocholithiasis (%) 22 (18.3%)
Chronic pancreatitis (%) 11 (9.2%)
Idiopathic biliary stricture (%) 11 (9.2%)
Biliary leakage (%) 5 (4.2%)






Other agents 69 (65.8%)
Clinical outcomes during the study period
Death due to biliary infection (%) 5 (4.2%)
Death due to underlying disease (%) 24 (20%)
Death due to other reasons (%) 9 (7.5%)
Total number of biliary stents 213






Number 113 100 n/a
Indwelling time in days (range) 64 (3–1202) 58 (1–1274) 0.559
Number of treatment episodes with multiple stenting 47 35 0.324
Stent occlusion rate (%) 13/113 (11.5%) 13/100 (13%) 0.739
Signs of cholangitis (fever, abdominal pain, jaundice, pus coming out of the
papilla) (%)
14/113 (12.4%) 13/100 (13%) 0.894
Median laboratory parameters at baseline (normal range)
Bilirubin (μmol/L; <17.1) 13.1 12.25 0.952
ALT (μkat/L; 0.17–0.85) 0.64 0.59 0.859
AST (μkat/L; 0.17–0.85) 0.74 0.58 0.160
AP (μkat/L; 0.58–2.15) 3.61 2.44 0.007
GGT (μkat/L; 0.17–1.19) 4.71 3.79 0.071
C-reactive protein (CRP) (mg/L; <5) 17.45 18.35 0.530
WBC (GPT/L; 3.5–9.8) 6.6 7.5 0.100
Abbreviations: ALT = alanine transaminase; AP = alkaline phosphatase; AST = aspartate transaminase; GGT = gamma-glutamyl transferase;
WBC = white blood cells; n/a = not applicable
doi:10.1371/journal.pone.0155479.t001
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ceftriaxone (31.7%), ciprofloxacin (28.3%), metronidazole (25.8%), or piperacillin/tazobactam
(25.8%), including combinations and sequential treatments. In patients with positive blood cul-
tures for Candida species, antifungal therapy with either fluconazole, voriconazole, anidulafun-
gin or liposomal amphotericin B was administered according to the results of the
microbiological susceptibility testing.
Detection of bacteria and fungi
All endoscopically retrieved stents showed microbial colonization, even after an indwelling
time of just one day. A total of 95 different bacterial and 13 different fungal species could be
detected (Table 2).
Up to seven different species were detected on a single stent (Fig 4). Polymicrobial coloniza-
tion (95.8%; 95% CI: 92.1% to 98%) was significantly more common than monomicrobial colo-
nization (4.2%; 95% CI: 2% to 7.9%) was (P<0.001). Enterococci were detected in 79.3% (169/
213; 95% CI: 73.3% to 84.6%) of all stents, Enterobacteriaceae in 73.7% (157/213; 95% CI:
67.3% to 79.5%), streptococci in 31.5% (67/213; 95% CI: 25.3% to 38.2%), anaerobes in 23.5%
(50/213; 95% CI: 18% to 29.7%), and staphylococci in 11.3% (24/213; 95% CI: 7.4% to 16.3%).
In 55.9% (119/213; 95% CI: 48.9% to 62.6%) of all cases, Candida species were involved. Species
identification revealed Enterococcus faecalis as the most common organism (50.2% of all
stents), followed by Candida albicans (48.4%), Escherichia coli (41.7%), Enterococcus faecium
(29.6%), Streptococcus anginosus (16.9%), Enterobacter cloacae (14.6%), Klebsiella oxytoca
(11.3%), and Candida glabrata (10.8%).
In patients with repeating stenting procedures, a clear tendency toward the establishment of
the same microbial flora on consecutive stents could be demonstrated, with a concordance rate
of 84% for Enterococcus faecalis, 83% for Candida albicans, 72% for Escherichia coli, and 60%
for Enteroccocus faecium as the most common pathogens.
The microbiological species analysis revealed no significant difference between the micro-
bial colonization of either polyethylene or polyurethane stents, regardless of their diameters,
except for Escherichia coli (P = 0.030). Further statistically significant differences were found
for colonization with Candida species (67.1% vs. 49.6%, P = 0.015), viridans group streptococci
Fig 3. Overview of microbiological results of cultures from sonicated stent fluids. Polymicrobial colonization of
biliary stents (95.8%) was significantly more common than single microbial colonization (4.2%, P <0.001) was.
doi:10.1371/journal.pone.0155479.g003
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Table 2. Spectrum of microorganisms* isolated from biliary stents.
Bacteria






Enterococcus faecalis 56/113 (49.6%) 51/100 (51%) 0.834
Enterococcus faecium 37/113 (32.7%) 26/100 (26%) 0.282
Enterococcus casseliflavus 12/113 (10.6%) 5/100 (5%) 0.204
Enterococcus avium 10/113 (8.8%) 5/100 (5%) 0.224
Enterococcus gallinarum 8/113 (7.1%) 3/100 (3%) 0.224
Enterococci (other species) 2/113 (1.8%) 4/100 (4%) 0.423
Streptococcus anginosus 20/113 (17.7%) 16/100 (16%) 0.741
Streptococcus parasanguinis 5/113 (4.4%) 6/100 (6%) 0.604
Streptococcus oralis/mitis 3/113 (2.7%) 7/100 (7%) 0.195
Streptococcus constellatus 4/113 (3.5%) 1/100 (1%) 0.374
Streptococci (other species) 8/113 (7.1%) 7/100 (7%) 0.982
Staphylococcus aureus 2/113 (1.8%) 3/100 (3%) 0.667
Staphylococcus epidermidis 5/113 (4.4%) 5/100 (5%) 1.000
Staphylococcus haemolyticus 2/113 (1.8%) 4/100 (4%) 0.423
Staphylococci (other species) 0/113 (0%) 3/100 (3%) 0.102
Others 10/113 (8.8%) 8/100 (8%) 0.824






Escherichia coli 55/113 (48.7%) 34/100 (34%) 0.030
Enterobacter cloacae 16/113 (14.2%) 15/100 (15%) 0.862
Klebsiella oxytoca 14/113 (12.4%) 10/100 (10%) 0.582
Klebsiella pneumoniae 9/113 (8%) 11/100 (11%) 0.448
Citrobacter spp. 8/113 (7.1%) 6/100 (6%) 0.751
Hafnia alvei 7/113 (6.2%) 4/100 (4%) 0.470
Pseudomonas aeruginosa 6/113 (5.3%) 6/100 (6%) 0.827
Proteus vulgaris 5/113 (4.4%) 6/100 (6%) 0.604
Proteus mirabilis 5/113 (4.4%) 2/100 (2%) 0.452
Morganella morganii 2/113 (1.8%) 4/100 (4%) 0.423
Others 13/113 (11.5%) 16/100 (16%) 0.340






Bacteroides spp. 11/113 (9.7%) 6/100 (6%) 0.316
Prevotella spp. 6/113 (5.3%) 7/100 (7%) 0.607
Veilonella spp. 4/113 (3.5%) 1/100 (1%) 0.374
Others 8/113 (7.1%) 7/100 (7%) 0.982






Candida albicans 55/113 (48.7%) 48/100 (48%) 0.922
Candida glabrata 13/113 (11.5%) 10/100 (10%) 0.724
Candida kefyr 5/113 (4.4%) 0/100 (0%) 0.062
Candida tropicalis 1/113 (0.9%) 4/100 (4%) 0.189
Candida (other species) 6/113 (5.3%) 4/100 (4%) 0.753
Others 3/113 (2.7%) 1/100 (1%) 0.624






Vancomycin-resistant enterococci (VRE) 18/125 (14.4%) 12/94 (12.8%) 0.728
(Continued)
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(40.8% vs. 26.3%, P = 0.032), and Pseudomonas aeruginosa (1.3% vs. 8.8%, P = 0.035), respec-
tively, comparing malignant and benign biliary strictures (S1 Table).
Matching rate of blood cultures and stent samples
In 42 of the 120 patients, a total of 58 blood cultures were obtained, of which 30 were positive.
In 17 of these (56.7%; 95% CI: 37.4% to 74.5%), there was agreement with the microbiological
results from biliary stents regarding the detected pathogen (the microbial species involved were
Enterococcus faecalis, Enterococcus faecium, Enterococcus avium, Streptococcus anginosus,
Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, and Candida albicans), and in 11
there was complete agreement with the respective phenotypic resistance profiles.
Five of 120 patients (4.2%) died due to biliary infections with sepsis. Four of these patients
were liver transplant recipients, and one patient suffered from metastatic gallbladder carci-
noma. Blood cultures detected Enterobacteriaceae (Escherichia coli, Klebsiella pneumoniae,
Klebsiella oxytoca, Serratia marcescens), Enterococci (Enterococcus faecium) and Pseudomonas
Table 2. (Continued)
Bacteria
Methicillin-resistant Staphylococcus aureus (MRSA) 2/2 (100%) 1/3 (33.3%) 0.400
ESBL-producing Enterobacteriaceae, resistant to 3 of 4 major antibiotic
classes§ (3MRGN)
17/129 (13.2%) 15/101 (14.9%) 0.716
Carbapenemase producing Enterobacteriaceae, resistant to 4 of 4 major
antibiotic classes§ (4MRGN)
1/129 (0.8%) 0/101 (0%) 1.000
Azole-resistant Candida species 25/80 (31.3%) 23/66 (34.8%) 0.645
Abbreviations: MRGN = multi-drug resistant Gram-negatives
§cephalosporins, acylaminopenicillins, fluoroquinolones, and carbapenems
*The complete list of species included (number of isolates in brackets, in descending order of frequency):
Enterococcus faecalis (107), Candida albicans (103), Escherichia coli (89), Enterococcus faecium (63), Streptococcus anginosus (36), Enterobacter cloacae
(31), Klebsiella oxytoca (24), Candida glabrata (23), Enterococcus casseliflavus (17), Enterococcus avium (15), Pseudomonas aeruginosa (12),
Enterococcus gallinarum (11), Hafnia alvei (11), Proteus vulgaris (11), Streptococcus parasanguinis (11), Staphylococcus epidermidis (10), Streptococcus
oralis/mitis (10), Prevotella melaninogenica (9), Citrobacter braakii (6), Morganella morganii (6), Staphylococcus haemolyticus (6), Bacteroides vulgatus (5),
Bacteroides fragilis (5), Candida kefyr (5), Candida tropicalis (5), Staphylococcus aureus (5), Streptococcus constellatus (5), Veilonella parvula (5),
Citrobacter freundii (4), Lactobacillus rhamnosus (4), Neisseria subflava (4), Raoultella planticola (4), Streptococcus gallolyticus ssp. gallolyticus (4),
Streptococcus salivarus spp. salivarus (4), Actinomyces odontolyticus (3), Bifidobacterium spp. (3), Enterococcus durans (3), Enterococcus hirae (3),
Haemophilus parainfluenzae (3), Serratia marcescens (3), Candida colliculosa (2), Candida krusei (2), Candida parapsilosis (2), Citrobacter koseri (2),
Citrobacter youngae (2), Cronobacter sakazakii (2), Enterobacter aerogenes (2), Lactobacillus plantarum (2), Prevotella buccae (2), Rothia mucilaginosa (2),
Streptococcus sanguinis (2), Acinetobacter baumannii (1), Abiotrophia defectiva (1), Actinomyces viscosus (1), Aeromonoas hydrophila (1), Bacillus
pumilus (1), Bacteroides uniformis (1), Bacteroides ovatus (1), Bacteroides stercoris (1), Bacteroides thetaiotaomicron (1), Candida dubliniensis (1),
Candida guilliermondii (1), Candida lambica (1), Candida norvegensis (1), Clostridium perfringens (1), Corynebacterium aurimucosum (1), Corynebacterium
bovis (1), Corynebacterium pseudodiphthericum (1), Corynebacterium striatum (1), Cryptococcus huminocola (1), Cryptococcus laurentii (1), Enterobacter
amnigenus (1), Escherichia hermanii (1), Gemella sanguis (1), Lactobacillus casei (1), Lactobacillus acidophilus (1), Lactococcus garvieae (1), Leifsonia
aquatica (1), Microbacter flavescens (1), Moraxella osloensis (1), Mycobacterium avium (1), Parabacteroides distasonis (1), Pediococcus pentosaceus (1),
Prevotella denticola (1), Prevotella oris (1), Proprionibacterium avidum (1), Propionibacterium acnes (1), Providencia rettgeri (1), Pseudomonas stutzeri (1),
Ralstonia insidiosa (1), Raoultella ornithinolytica (1), Rhizobium radiobacter (1), Saccharomyces cerevisiae (1), Salmonella spp. (1), Staphylococcus capitis
(1), Staphylococcus saprophyticus (1), Staphylococcus vitulinus (1), Streptococcus suis (1), Streptococcus equinus ssp. zooepidemicus (1),
Streptococcus gallolyticus ssp. pasteurianus (1), Streptococcus infantarius spp. coli (1), Streptococcus pneumoniae (1), Trueperella bernardiae (1), Vibrio
alginolyticus (1), Yersinia pseudotuberculosis (1).
doi:10.1371/journal.pone.0155479.t002
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aeruginosa as triggering pathogens. Antimicrobial treatment was performed by carbapenems
and linezolid according to the results of the microbiological susceptibility testing.
Time dependency of stent colonization
The time-dependent graphical representation of stent colonizers grouped by enterococci,
Enterobacteriaceae, Candida species, and streptococci showed a significantly different distribu-
tion of enterococci versus Candida spp. (P<0.001), and enterococci versus streptococci
(P = 0.005), respectively (log-rank test) (Fig 5).
Fig 4. Scatter plot of stent duration in place (in days) vs. number of detectedmicroorganisms.
doi:10.1371/journal.pone.0155479.g004
Fig 5. Stent duration in place (in days) versusmicrobiological isolates from sonicated stent fluids,
grouped by predominant enterococci, Enterobacteriaceae, Candida spp., and streptococci.
doi:10.1371/journal.pone.0155479.g005
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Stent colonization with respect to antibiotic therapy
Stent colonization differed significantly with respect to the proportion of Candida species (63%
vs. 46.7%, P = 0.023) in patients receiving prolonged antibiotic therapy (Fig 6). In the other
groups, no significant differences were found.
Antimicrobial resistance profiles
Antimicrobial resistance profiles, grouped by Enterococcus faecalis, Enterococcus faecium,
streptococci, Escherichia coli, anaerobes, Candida albicans, and non-albicans Candida (NAC)
species, are distributed in Fig 7. The rate of vancomycin resistance among enterococci was
13.7% (30 of 219 isolates; 95% CI: 9.4% to 19%; 0.9% in Enterococcus faecalis and 28.6% in
Enterococcus faecium). The proportion of ESBL producers among Enterobacteriaceae with co-
resistance to ciprofloxacin was 13.9% (32/230; 95% CI: 9.7% to 19.1%). There was only one
patient with the detection of carbapenem-resistant isolates due to known intestinal coloniza-
tion by a Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae
strain, which was also detected on a biliary stent. Azole-resistant Candida species accounted
for 32.9% (48/146; 95% CI: 25.3% to 41.1%) of the isolates.
Independent predictors for colonization with enterococci andCandida
spp.
Logistic regression analysis (using the following independent variables: age, gender, malig-
nant biliary strictures, preceding liver transplantation, presence of diabetes mellitus, repeated
ERC, prolonged antibiotic therapy>48 hours, and length of hospital stay>7 days) revealed
that repeated ERC intervention was an independent predictor for the occurrence of entero-
cocci (odds ratio [OR] 9.75; 95% CI: 1.24 to 76.43), and presence of a malignant biliary stric-
ture was an independent predictor for the occurrence of Candida spp. (OR 2.55; 95% CI: 1.08
to 6.05).
Fig 6. Distribution of bacterial and fungal species depending on the use of antibiotics. Stent
colonization differed significantly with respect to the proportion of Candida species (46.7% vs. 63%,
P = 0.023) in patients receiving prolonged antibiotic therapy.
doi:10.1371/journal.pone.0155479.g006
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Discussion
In this study, 213 stents from 120 patients with the detection of 95 different bacteria and 13 dif-
ferent fungal species were included in the final analysis. Compared to previous analyses with a
similar design and methodology [17–20,24], our study is distinguished by the large sample size;
the use of sonication facilitating a better release of pathogens from the biofilm on the inner sur-
face of the stents [10,29,30]; the application of MALDI-TOF mass spectrometry for precise
identification of microorganisms; and a detailed antimicrobial susceptibility analysis involving
28 antibiotics and seven antifungal agents.
Our results reveal the highest detection rate for both enterococci (79.3% of all stents) and
Candida species (55.9% of all stents) of all studies investigating patients with biliary stents
[10,17,19,20,23–27,35–37]. The occurrence of both pathogen groups was significantly associ-
ated with an increased indwelling time of stents (Fig 5). Moreover, previous antibiotic therapy
seems to exert significant selective pressure as also reported elsewhere [25,27]. Thus, the stent
colonization differed significantly with respect to the proportion of Candida species (46.7% vs.
63%, P = 0.023) in patients receiving earlier prolonged antibiotic therapy. Unquestionably, this
pathogen shift has clinical relevance, as conventional doctrines regarding the microbiology of
the biliary tract describe a predominance of Enterobacteriaceae and anaerobes, followed by
enterococci and streptococci [38,39].
Preceding studies have shown a clear association between biliary stent insertion and changes
in the spectrum of pathogens in the bile toward enterococci [10,23,36], as well as the increased
incidence of bacterial and fungal colonization associated with pre-operative biliary drainage
[37]. In a study performed by Weber et al. in Germany, enterococci were by far the most preva-
lent genera, reaching detection rates of>70% in patients with stent-associated cholangitis [23].
Fig 7. In vitro antibiotic susceptibilities of bacterial and fungal isolates, grouped by Enterococcus faecalis, Enterococcus faecium,
streptococci, Escherichia coli,Candida albicans, and non-albicansCandida (NAC) species.Minimum inhibitory concentrations (MICs) were
determined employing Industrial Organization for Standardization (ISO) 20766–1 or E-test, and the results were interpreted according to current
European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints (www.eucast.org, 2015 edition).
doi:10.1371/journal.pone.0155479.g007
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Thus, the high proportion of enterococcal species of 79.3% in our study is in line with previous
reports, revealing that samples collected from patients with stents had a significantly higher
incidence of Enterococcus spp. compared to bile samples from patients without stents, corrobo-
rating a “stent tropism” of enterococci [10,23,36]. Furthermore, the number of enterococci iso-
lated from blood cultures appeared to be higher in stent-associated cholangitis episodes [23].
In this context, repeated ERC intervention was an independent predictor for the occurrence of
enterococcal species (OR 9.75) in our study. The well-described risk factors of Candida in bile
include biliary stenting, malignant strictures, and repeated interventions [23,26]. In such
patients, prolonged antibiotic treatment apparently facilitates biliary colonization by Candida
spp. [26,27], as also shown in our study. From a clinical point of view, the detection of signifi-
cantly more Candida spp. (as well as viridans group streptococci) in patients with malignant
disease may also reflect a certain degree of tumor-associated immunological dysfunction.
The majority of stent extractions were performed electively, and therefore, blood cultures
were collected only in patients presenting with acute cholangitis or general signs of infection.
Because the matching rate of blood cultures and stent isolates was 56.7% in our study, we
assume that corresponding shifts in the biliary pathogen spectrum toward enterococci and
Candida spp. may be clinically relevant in the case of stent-associated acute cholangitis. How-
ever, Schneider et al. already pointed out that the hypothesis that microorganisms isolated
from the biofilms on biliary stent surfaces are similar to microorganisms in the bile fluid still
has to be proven [10], as concomitant bile cultures were not systematically collected in most
available studies and systematic microbiological typing was omitted. Negm et al. concluded in
a recent study of endoscopically obtained bile aspirates that all microorganisms found in posi-
tive blood cultures were also found in bile samples [26], indicating that biliary culture results
alone are as effective as positive blood cultures. In the literature, the clinical relevance of endo-
scopically performed bile collection for microbiological analysis is discussed controversially
[10,26,35–37]. In a study performed by Park et al. in Korea, in 258 bacteremic cholangitis epi-
sodes, complete agreement with blood cultures was observed only in 31% of the bile samples
[35]. Fifty percent of the bile specimens showed partial agreement with the blood culture find-
ings, and 19% of the bile cultures revealed completely different microorganisms compared to
the blood cultures analyzed. The degree of coincidence between the bile and blood cultures for
Escherichia coli, Klebsiella spp., enterococci, and streptococci was 71%, 53%, 35%, and 27%,
respectively [35]. In our setting, the risk of cholangitis was significantly higher in patients with
stent occlusion (38.5% vs. 9.1%, P<0.001). In the study performed by Schneider et al., biliary
stents occluded after a median indwelling time of 70 days [10]. However, stent occlusion
resulted in cholangitis or cholestasis in only 35% of the cases. Thus, stent occlusion is not
always associated with clinical symptoms.
The question of the optimal stent surface with regard to the prevention of occlusion has not
yet been answered satisfactorily, whereby an advantage for Teflon™ (polytetrafluorethylene)
compared to other plastics could be demonstrated [6]. Several studies have shown that antimi-
crobial coatings on medical devices are effective against the formation of microbial biofilms
[10]. Therefore, the use of special coatings, such as diamond-like carbons (DLC) or silver-
nanoparticles, seems to be a promising approach for reducing biofilm formation on medical
implants [40,41]. On the other hand, there has been no evidence so far that modified surfaces
offer effective protection against the apparently growing threat of colonization by enterococci
and Candida species.
Regarding antimicrobial resistance profiles, in our environment, resistance rates to vanco-
mycin in enterococci (0.9% in E. faecalis, and 28.6% in E. faecium), the rate of co-resistance to
ciprofloxacin in ESBL-producing Enterobacteriaceae (13.9%), and the resistance rate to carba-
penems in Enterobacteriaceae (0.4%) were still within feasible ranges. However, taking into
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account the azole resistance rate of 32.9%, significant failure rates of fluconazole-based empiri-
cal antifungal therapies for Candida infections have to be considered. It is well known that
numerous interventional ERC procedures accompanied by antibiotic therapy predispose for
increased antimicrobial resistance in patients with acute cholangitis [25,27], and enterococcal
species are often involved in this process [42,43]. Therefore, adequate microbiological diagno-
sis is essential and should include analysis of the extracted stents.
Multi-drug resistance is generally on the rise, particularly among Enterobacteriaceae [44–
47]. Regarding the detection of carbapenem-resistant Enterobacteriaceae (CRE) in a single
patient in our study, it is important to keep in mind that biliary colonization with CRE may
have enormous clinical relevance in certain patient groups, such as liver transplant recipients
[48]. Taking into consideration existing hygiene recommendations for the clinical manage-
ment of affected patients in Germany, we propose active surveillance and stringent contact iso-
lation precautions in hospitals, particularly in the endoscopy unit [49]. Invasive procedures as
well as the use of antibiotics should be limited to clear medical indications.
In the overall assessment, our study has limited representativeness due to its monocentric
design, and it displays several limitations: Firstly, the contamination of samples during endo-
scopic retrieval of stents cannot be excluded. Secondly, the choice and indwelling times of poly-
ethylene or polyurethane stents inserted in the bile duct were arbitrary. Therefore, the timing
of stent extraction and the indications for stent placement were not standardized. Thirdly, clin-
ical selection bias cannot be excluded because it was a non-randomized study, and the results
of the microbiological analysis are certainly influenced by the use of antimicrobial agents.
Conclusions
We conclude that enterococci and Candida species play an important role in the microbial col-
onization of biliary stents. Therefore, empirical antimicrobial treatment of stent-associated
cholangitis should be guided toward enterococci, Enterobacteriaceae, streptococci, anaerobes,
and Candida. To determine causative pathogens, an accurate microbiological analysis of the
extracted stent(s) may be helpful. Assessing the presence of pathobionts versus symbionts in
the biliary tract is an important task of future clinical studies.
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